Moreover, the higher risk of comorbid insulin resistance in schizophrenia was associated with higher levels of CRP, suggesting that prevention or treatment of inflammation may be an advantageous option for preventing or treating comorbid IR in schizophrenia (19). Here, CRP is linked to schizophrenia.